Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 10 matches for

The collective force of cancer research, outreach and care across the city of Oxford, translating discoveries into better care for cancer patients.

[Video] Patient and Public Involvement with Oxford Cancer

The World Cancer Day theme 2025-2027 “United by Unique” places people at the centre of care and their stories at the heart of the conversation. At Oxford Cancer, we are committed to supporting Patient and Public Involvement (PPI) in research; we aim to build an inclusive community of PPI representatives who are involved in the design and delivery of cutting-edge cancer projects.

BLOG: Patient and Public Involvement in Research

Are you interested in public engagement with cancer research? Julliet Lwiindi, Oxford Cancer's Public Engagement and Involvement Officer, shares a little about the ways in which you can engage with our Oxford Cancer Patient and Public Involvement (PPI) group.

Postponed: Oxford Cancer Celebratory Fun Run

The Oxford Cancer Celebratory Fun Run has been postponed. Apologies for any Inconvenience.

[VIDEO] LungVax: the world’s first vaccine to prevent lung cancer in people with a high risk of the disease - meet the team

Researchers at the University of Oxford, the Francis Crick Institute and University College London have been granted funding from Cancer Research UK (CRUK) and the CRIS Cancer Foundation to develop ‘LungVax’, the world’s first vaccine to prevent lung cancer in people with a high risk of the disease. Hear from LungVax team members Professor Sarah Blagden, Professor Mariam Jamal-Hanjani and Patient and Public Involvement Representative Janette Rawlinson in this video interview from CRUK.

Immunotherapy: finding hidden ways to treat cancer

Giamp Valenzano, a DPhil in Cancer Science student, joins forces with Oxford Sparks to deliver a video explaining how his research on immunotherapy aims to help treat cancer

Patient and Public Involvement and Engagement: Working together to improve Cancer Care by Sue Duncombe

Sue Duncombe shares her experience of Patient and Public Involvement and Engagement. After her husband died of prostate cancer, Sue wanted to support research in the hope other families wouldn't experience the same loss.

Patient Priorities in Cancer Research - What matters most to patients with MDS & MPN?

In this blog, Catriona Gilmour Hamilton – Patient and Public Involvement Manager - discusses why our Patient and Public Involvement team is generating lists of the ‘top ten’ priorities for patients with a range of cancer types, and why they are so crucial for researchers.

What matters most to people with primary liver cancer?

Oxford Cancer will host workshop on patient priorities for those with HCC (hepato-cellular carcinoma).

Patient and Public Involvement profile: In conversation with Hazel Beaver

At Oxford Cancer, we are committed to supporting Patient and Public Involvement (PPI) in research; we recognise the benefits of placing the needs and experiences of those affected by cancer at the heart of decision-making.

Patient and Public Involvement profile: In conversation with Sally Jeans

Involving patients and the public in cancer research can help to guide the direction of medical research in a way that benefits those that need it most.